Interval-Shared Information Integration and False-Negative Association Reduction in Multi-Source MiRNA-Disease

Insights

This study introduces ISFNMDA, a novel computational model for identifying microRNA-disease associations (MDAs). It enhances prediction accuracy by integrating multi-source similarities and optimizing graph topology, improving disease etiology understanding.

Area of Science:

  • Bioinformatics
  • Genomics
  • Computational Biology

Background:

  • MicroRNAs (miRNAs) are critical in disease development, making miRNA-disease association (MDA) identification vital for understanding disease etiology.
  • Existing computational models for MDA prediction face challenges with multi-source similarity interactions and "false-negative" associations.

Purpose of the Study:

  • To propose ISFNMDA, a novel computational model for inferring potential miRNA-disease associations (MDAs).
  • To address limitations in current MDA prediction models, specifically regarding multi-source similarity integration and "false-negative" data.

Main Methods:

  • Leveraging multi-view collaborative learning for feature extraction from multi-source miRNA and disease similarities.
  • Optimizing association topology using graph structure momentum contrastive learning to reduce spurious correlations.
  • Employing Pearson correlation coefficient for pairwise constraints and constructing interval-shared information constraints.

Main Results:

  • ISFNMDA effectively integrates multi-source similarities into a unified feature space.
  • The model optimizes graph topology by reducing spurious correlations through momentum contrastive learning.
  • Experimental results show ISFNMDA outperforms existing methods in predicting potential MDAs, with case studies validating its efficacy.

Conclusions:

  • ISFNMDA provides an effective computational framework for accurate miRNA-disease association prediction.
  • The model's ability to handle complex data interactions and optimize graph structures offers significant advancements in disease etiology research.
  • This approach enhances the understanding of disease mechanisms and facilitates the identification of novel therapeutic targets.